What's old is new: Reconfiguring known antibiotics to fight drug resistance. (Q53761918)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2016

edit

Language	Label	Description	Also known as
English	What's old is new: Reconfiguring known antibiotics to fight drug resistance.	scientific article published in November 2016

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27824813

retrieved

19 May 2018

reference URL

http://europepmc.org/abstract/MED/27824813

title

What's old is new: Reconfiguring known antibiotics to fight drug resistance. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27824813

retrieved

19 May 2018

reference URL

http://europepmc.org/abstract/MED/27824813

author name string

Shraddha Chakradhar

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27824813

retrieved

19 May 2018

reference URL

http://europepmc.org/abstract/MED/27824813

language of work or name

English

0 references

publication date

1 November 2016

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27824813

retrieved

19 May 2018

reference URL

http://europepmc.org/abstract/MED/27824813

published in

Nature Medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27824813

retrieved

19 May 2018

reference URL

http://europepmc.org/abstract/MED/27824813

volume

22

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27824813

retrieved

19 May 2018

reference URL

http://europepmc.org/abstract/MED/27824813

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27824813

retrieved

19 May 2018

reference URL

http://europepmc.org/abstract/MED/27824813

page(s)

1197-1199

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27824813

retrieved

19 May 2018

reference URL

http://europepmc.org/abstract/MED/27824813

cites work

Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM1116-1197

retrieved

21 January 2018

SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM1116-1197

retrieved

21 January 2018

In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM1116-1197

retrieved

21 January 2018

Antimicrobial activity of solithromycin against serotyped macrolide-resistant Streptococcus pneumoniae isolates collected from U.S. medical centers in 2012.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNM1116-1197

retrieved

21 January 2018

Identifiers

DOI

10.1038/NM1116-1197

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27824813

retrieved

19 May 2018

reference URL

http://europepmc.org/abstract/MED/27824813

Dimensions Publication ID

1003297921

0 references

PubMed publication ID

27824813

1 reference

stated in

Europe PubMed Central

PubMed publication ID

27824813

retrieved

19 May 2018

reference URL

http://europepmc.org/abstract/MED/27824813

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53761918&oldid=2212285584"